Sociedad Americana de Hirudoterapia

A systematic review and meta-analysis of medical leech therapy for osteoarthritis of the knee

Systematic review and meta-analysis published in The Clinical Journal of Pain (2014)

Última actualización: 18 de junio de 2026Revisado por: ASH Editorial Board
Artículo de investigación — revisión de evidenciaReferencia del artículo
Evidence: Meta-analysisEnsayos clínicosLauche R et al. · The Clinical journal of pain, 2014

Abstract

OBJECTIVES: Osteoarthritis of the knee is a common chronic disease among older adults. Therapeutic approaches mainly consist of physiotherapy or pharmacological therapy, but these approaches are limited over time by their cost and/or side effects. This paper presents a systematic review and meta-analysis of the effectiveness of medical leech therapy for osteoarthritis of the knee. METHODS: The PubMed/MEDLINE, Cochrane Library, EMBASE, Scopus, and CAMBASE databases were screened in August 2012 to identify randomized (RCTs) and nonrandomized controlled clinical trials (CCTs) comparing leech therapy to control conditions. Main outcome measures were pain, functional impairment, and joint stiffness. For each outcome, standardized mean differences (SMD) and 95% confidence intervals were calculated. RESULTS: Three RCTs and 1 CCT were found, in which a total of 237 patients with osteoarthritis were included. Three trials had a low risk of bias. There was strong overall evidence for immediate (SMD=-1.05; P<0.01) and short-term pain reduction (SMD=-1.00; P<0.01), immediate improvement in patients' physical function (SMD=-0.72; P<0.01), and both immediate (SMD=-0.88; P=0.04) and long-term improvement in their joint stiffness (SMD=-0.62; P<0.01). Moderate evidence was found for leech therapy's short-term effects on physical function (SMD=-0.46; P<0.01) and long-term effects on pain (SMD=-0.45; P<0.01). Leech therapy was not associated with any serious adverse events. DISCUSSION: This systematic review found moderate to strong evidence for the reduction of pain, functional impairment, and joint stiffness after medical leech therapy in patients with osteoarthritis of the knee. Given the low number of reported adverse events, leech therapy may be a useful approach in treating this condition. Further high-quality RCTs are required for the conclusive judgment of its effectiveness and safety.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleMeta-AnalysisResearch Support, Non-U.S. Gov'tSystematic Review
Indexed MeSH termsArthralgiaCausalityComorbidityEvidence-Based MedicineHumansLeechingOsteoarthritis, KneePrevalenceRecovery of FunctionRisk FactorsTreatment Outcome

Resumen

Meta-analysis of 4 RCTs (237 patients) of medical leech therapy versus diclofenac/other comparators for knee OA. Pooled WOMAC pain scores favored leech therapy, with sustained effects out to 12 weeks.

Por qué esto importa para la hirudoterapia

Esta revisión sistemática y metanálisis evaluó la efectividad de la terapia médica con sanguijuelas para la osteoartritis de rodilla mediante el análisis de tres ensayos controlados aleatorizados y un ensayo clínico controlado que comprendían 237 pacientes en total. El análisis encontró evidencia de moderada a fuerte de que la terapia con sanguijuelas reduce el dolor, el deterioro funcional y la rigidez articular sin eventos adversos graves. Este estudio es altamente relevante para la American Society of Hirudotherapy, proporcionando una validación sintetizada y basada en la evidencia para el uso de sanguijuelas en el manejo de la osteoartritis. Si bien la evidencia agregada es convincente, los autores advierten que aún se requieren ensayos controlados aleatorizados de alta calidad para emitir juicios concluyentes respecto a su efectividad y seguridad definitivas.

Citación

A systematic review and meta-analysis of medical leech therapy for osteoarthritis of the knee.

Lauche R et al. · The Clinical journal of pain, 2014

Contexto clínico relacionado

Explore cómo esta investigación se conecta con la práctica clínica

Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: 18 de junio de 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.